These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31602823)

  • 21. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy.
    Liao J; Jia Y; Wu Y; Shi K; Yang D; Li P; Qian Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1581. PubMed ID: 31429208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary delivery systems for polyphenols.
    Trotta V; Scalia S
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1043-1052. PubMed ID: 28276786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma.
    Kabary DM; Helmy MW; Abdelfattah EA; Fang JY; Elkhodairy KA; Elzoghby AO
    Eur J Pharm Biopharm; 2018 Sep; 130():152-164. PubMed ID: 29964122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breathable Medicine: Pulmonary Mode of Drug Delivery.
    Gandhimathi C; Venugopal JR; Sundarrajan S; Sridhar R; Tay SS; Ramakrishna S; Kumar SD
    J Nanosci Nanotechnol; 2015 Apr; 15(4):2591-604. PubMed ID: 26353470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: Critical appraisal of newer developments and challenges to clinical transition.
    Gao X; Guo L; Li J; Thu HE; Hussain Z
    J Control Release; 2018 Dec; 292():29-57. PubMed ID: 30359665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease.
    Liang Y; Mak JCW
    Curr Pharm Des; 2021; 27(12):1469-1481. PubMed ID: 33243107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease.
    Seshadri DR; Ramamurthi A
    Front Pharmacol; 2018; 9():759. PubMed ID: 30061830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macromolecule nanotherapeutics: approaches and challenges.
    Tyagi P; Santos JL
    Drug Discov Today; 2018 May; 23(5):1053-1061. PubMed ID: 29326081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New perspectives in nanomedicine.
    Thorley AJ; Tetley TD
    Pharmacol Ther; 2013 Nov; 140(2):176-85. PubMed ID: 23811125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Nanomaterials for Asthma Treatment.
    Zuo X; Guo X; Gu Y; Zheng H; Zhou Z; Wang X; Jiang S; Wang G; Xu C; Wang F
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.
    Ibarra-Sánchez LÁ; Gámez-Méndez A; Martínez-Ruiz M; Nájera-Martínez EF; Morales-Flores BA; Melchor-Martínez EM; Sosa-Hernández JE; Parra-Saldívar R; Iqbal HMN
    J Drug Deliv Sci Technol; 2022 Apr; 70():103219. PubMed ID: 35280919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects.
    Gulati N; Chellappan DK; MacLoughlin R; Dua K; Dureja H
    Life Sci; 2021 Nov; 285():119969. PubMed ID: 34547339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
    Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
    Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.